Skip to main content

Table 2 Relationship of platelet and all-cause mortality in stroke patients with cancer (Unweighted)

From: The influence of baseline platelet on mortality risk in stroke and cancer patients: a cross-sectional analysis of the NHANES database

 

Crude model HR(95% CI) P

Model 1 HR(95% CI) P

Model 2 HR(95% CI) P

PLT

1.00(0.99,1)

0.08

0.99(0.99,1.00)

0.01

0.996(0.99,1.00)

0.04

PLT category

 Lower PLT

Ref

 

Ref

 

Ref

 

 Higher PLT

0.61(0.38,0.98)

0.04

0.43(0.24,0.77)

0.005

0.58(0.35,0.96)

0.03

  1. Crude model was unadjusted. Model 1 controlled age, gender, race, family income-poverty ratio, educational level, alcohol history, smoke history, hypertension, diabetes, coronary heart disease, glycosylated hemoglobin, body mass index, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, total cholesterol, triglyceride, white blood cell, red blood cell, lymphocyte, neutrophil and hemoglobin. Model 2 was adjusted for age, gender, BMI, white blood cell and neutrophil
  2. Abbreviation: PLT platelet
Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us